Replimune Group Inc REPL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 08/05/22 EDT
20.50UNCH (UNCH)
Volume
5,161
Close
20.50quote price arrow up+0.05 (+0.24%)
Volume
290,418
52 week range
13.05 - 36.97
Loading...
  • Open19.92
  • Day High20.55
  • Day Low19.25
  • Prev Close20.45
  • 52 Week High36.97
  • 52 Week High Date08/06/21
  • 52 Week Low13.05
  • 52 Week Low Date05/11/22

Key Stats

  • Market Cap1.011B
  • Shares Out49.31M
  • 10 Day Average Volume0.15M
  • Dividend-
  • Dividend Yield-
  • Beta1.98
  • YTD % Change-24.35

KEY STATS

  • Open19.92
  • Day High20.55
  • Day Low19.25
  • Prev Close20.45
  • 52 Week High36.97
  • 52 Week High Date08/06/21
  • 52 Week Low13.05
  • 52 Week Low Date05/11/22
  • Market Cap1.011B
  • Shares Out49.31M
  • 10 Day Average Volume0.15M
  • Dividend-
  • Dividend Yield-
  • Beta1.98
  • YTD % Change-24.35

RATIOS/PROFITABILITY

  • EPS (TTM)-2.51
  • P/E (TTM)-8.16
  • Fwd P/E (NTM)-7.24
  • EBITDA (TTM)-113.786M
  • ROE (TTM)-25.94%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)6.56%

EVENTS

  • Earnings Date11/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Replimune Group Inc

There is no recent news for this security.

Profile

MORE
Replimune Group, Inc. is a clinical-stage biotechnology company engaged in the business of oncolytic immunotherapy to treat the cancer patients. The Company is advancing a pipeline of tumor-directed oncolytic immunotherapies derived from its RPx platform to fill unmet need across cancer types. The Company's lead product candidate, RP1, is a selectively replicating version of HSV-1 that expresses GALV-GP R and human GM-CSF. RP1 is designed to treat more immune responsive tumor...
Dieter Weinand
Independent Non-Executive Chairman of the Board
Philip Astley-Sparke
Chief Executive Officer, Director
Robert Coffin Ph.D.
President, Director, Chief Research & Development Officer
Colin Love Ph.D.
Chief Operating Officer
Jean Franchi CPA
Chief Financial Officer, Treasurer
Address
500 Unicorn Park Dr
Woburn, MA
01801-3377
United States

Top Peers

SYMBOLLASTCHG%CHG
ERAS
Erasca Inc
8.96+0.80+9.80%
CRNX
Crinetics Pharmaceuticals Inc
22.20+1.20+5.71%
RCKT
Rocket Pharmaceuticals Inc
15.56+0.46+3.05%
GOSS
Gossamer Bio Inc
12.95+0.10+0.78%
ACRS
Aclaris Therapeutics Inc
18.00+1.23+7.33%